Aconiazide, a hydrazone derivative of isoniazid, has been proposed for the treatment of tuberculosis. The toxicity of aconiazide was assessed by treating male and female Fischer 344 (F344) rats daily by gavage for 6 months at doses up to 400 mg/kg body wt. For comparison, the toxicity of isoniazid was determined following treatment in an identical manner at equimolar doses. Aconiazide resulted in only one death during the 6-month experiment, whereas isoniazid caused a significant increase in morbidity and mortality. Each drug induced significant dose-related decreases in body weight in both sexes, and isoniazid caused a significant decrease in liver weight in male rats. Isoniazid also induced centrilobular hepatic necrosis in male rats, a lesion not observed upon aconiazide treatment. Plasma drug levels were ≥10-fold greater in rats administered isoniazid as compared to aconiazide. The higher levels of free drug observed with isoniazid may contribute to greater toxicity of isoniazid compared to aconiazide.
AHFS. (1990) Isoniazid. In: McEvory GK, ed. AHFS Drug Information 1990.Bethesda: American Society of Hospital Pharmacists, 344–8.
2.
Alford RH. (1990) Antimycobacterial agents. In: Mandell GL, Douglas RG Jr, Bennett JE, eds., Principles and Practice of Infectious Diseases, 3rd ed. New York: Churchill Livingstone, 350–60.
3.
Bailer AJ, Portier CJ. (1988) Effects of treatment-induced mortality and tumor-induced mortality on test for carcinogenicity in small samples.Biometrics44:417–31.
4.
Banerjee A, Dabnau E, Quemard A, et al. (1994) inhA, a gene encoding a target for isoniazid and ethionamide inMycobacterium tuberculosis. Science263:227–30.
5.
Barnes PF, Bloch AB, Davidson PT, Snider DE Jr. (1991) Tuberculosis in patients with human immunodeficiency virus infection.N Engl J Med324:1644–50.
6.
Bernstein J, Lott WA, Steinberg BA, Yale HL. (1952) Chemotherapy of experimental tuberculosis. V. Isonicotinic acid hydrazide (Nydrazid) and related compounds.Am Rev Tuberc65:357–64.
7.
Bloom BR. (1992) Tuberculosis. Back to a frightening future.Nature [Lond]358:538–9.
8.
CMRL. (1961) New Drug Submission for Isonicotinylhydrazone of 2-Formyl-Phenoxy acetic Acid (Antituberculous Compound 377) to Department of National Health and Welfare, Ottawa.Toronto, Ontario, Canada: Connaught Medical Research Laboratories, University of Toronto.
9.
Davidson PT, Le HQ. (1992) Drug treatment of tuberculosis–1992.Drugs43:651–73.
10.
Dooley KL, Hansen EB Jr, Sheldon WG, Beland FA. (1993) Fourteen-day, repeat-dose toxicity evaluation of aconiazide administered orally to male and female Fischer 344 rats.J Am Coll Toxicol12:329–36.
11.
Fox HH. (1952) The chemical approach to the control of tuberculosis.Science116:129–34.
12.
Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. (1993) The emergence of drug-resistant tuberculosis in New York City.N Engl J Med328:521–6.
13.
Garibaldi RA, Drusin RE, Ferebee SH, Gregg MB. (1972) Isoniazid-associated hepatitis. Report of an outbreak.Am Rev Respir Dis106:357–65.
14.
Handin RI. (1985) Hemorrhagic disorders II. Platelets and purpura. In: Beck WS, ed. Hematology. Cambridge: MIT Press, 433–56.
Holm S. (1979) A simple sequentially rejective multiple test procedure.Scand J Stat6:65–70.
17.
Klaassen CD, Rozman K. (1991) Absorption, distribution, and excretion of toxicants. In: Amdur, MO, Doull J, Klaassen CD, eds. Casarett and Doull's Toxicology: The Basic Science of Poisons, 4th ed. New York: McGraw-Hill, 50–87.
18.
Kleinbautn DG. (1973) A generalization of the growth curve model which allows missing data.J Multivariate Anal3:117–24.
19.
Middlebrook G. (1952) Sterilization of tubercle bacilli by isonicotinic acid hydrazide and the incidence of variants resistant to the drug in vitro.Am Rev Tuberc65:765–7.
20.
Murray CJL, Styblo K, Rouillon A. (1990) Tuberculosis in developing countries: burden, intervention and cost.Bull Int Union Tuberc Lung Dis65:6–24.
21.
Pansy F, Stander H, Donovick R. (1952) In vitro studies on isonicotinic acid hydrazide.Am Rev Tuberc65:761–4.
22.
Park KS, Sohn DH, Veech RL, Song BJ. (1993) Translation activation of ethanol-inducible cytochrome P450 (CW2E1) by isoniazid.Eur J Pharmacol248:7–14.
23.
Ryan DE, Ramanathan L, Iida S, et al. (1985) Characterization of rat hepatic microsomal cytochrome P-450 induced by isoniazid.J Biol Chem260:6385–93.
24.
Siebenmann CO, Zubrys A. (1955) Effect of isonicotinylhydrazones of substituted benzaldehydes on established experimental tuberculosis in mice. In: Welch H, Marti-Ibanez F, eds. Antibiotics Annual 1954-1955.New York: Medical Encyclopedia, 442–50.
25.
Snider DE Jr, Roper WL. (1992) The new tuberculosis.N Engl J Med326:703–5.
26.
Timbrell JA, Mitchell IR, Snodgrass WR, Nelson SD. (1980) Isoniazid hepatotoxicity: the relationship between covalent binding and metabolism in vivo.J Pharmacol Exp Ther213:364–9.
Wolford ST, Schroer RA, Gohs FX, et al. (1986) Reference range data base for serum chemistry and hematology values in laboratory animals.J Toxicol Environ Health18:161–88.
29.
Zhang Y, Heym B, Allen B, Young D, Cole S. (1992) The catalase-peroxidase gene and isoniazid resistanceof Mycobacterium tuberculosis. Nature [Lond]358:591–3.
30.
Zubrys A, Siebenmann CO. (1955) Antituberculous isonicotinylhydrazones of low toxicity.Can J Chem33:1–4.
